Global Peptide Therapeutics Market Expected to Reach a Value of over US$ 46 Bn by 2024

ALBANY, USA, 2018-Apr-12 — /EPR Network/ —Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future.

Get Exclusive Sample Copy @ https://www.mrrse.com/sample/1023

This research gives a broad overview of the market considering all major aspects sufficient enough to assist the reader decide on goals and set up benchmarks. All latest trends, developments and opportunities are covered in this research. Moreover, the growth of the entire market is impacted by several factors. All these are analyzed in detail and the impact level of these factors is slated. A detailed market segmentation is carried out which gives justice to the credibility of the research report. Future projections have been carried out for a duration of eight years. All data and statistical analyses have been carried out considering all major regions of North America, Asia Pacific (APAC), Europe, Latin America and Middle East and Africa (MEA).

Global Peptide Therapeutics Market: Forecast

The global peptide therapeutics market is projected to grow at a CAGR of 9.10% throughout the assessment period, 2016-2024. The market, in 2015, was valued at US$ 21.3 Bn and is projected to reflect a value of about US$ 46 Bn by the end of 2024.

Global Peptide Therapeutics Market: Segmental Analysis

The global market for peptide therapeutics has been segmented by application (cancer, CVD, metabolic, GIT, respiratory, dermatology, anti-infective, renal, CNS, others), by route of administration (oral, parental, others), by type (generic and innovative), by technology (solid phase, liquid phase and hybrid phase), by type of molecule (vasopressin, calcitonin, somatostatin, natriuretic, immunopeptide, others), by API peptide type (CMO and In-house) and by geography.

• By application, the cancer segment is more likely to be the leading segment in terms of revenue. Increasing mortality due to cancer has forced the players in this market to develop new products and drugs. This aspect has impacted the global market for peptide therapeutics at a substantial level
• By route of administration, the parental segment dominated the market in 2015. The oral segment is also expected to grow by the end of 2024 at a higher growth rate
• North America region dominated the global market for peptide therapeutics by region. In 2015 it accounted for a market share of around 38.8% and is anticipated to witness growth and dominate the entire market in the coming years, followed by Europe

Browse Full Report with Table of Content, List of Table and Figures – https://www.mrrse.com/peptide-therapeutics-market

Global Peptide Therapeutics Market: Dynamics

The global market for peptide therapeutics is poised to witness significant growth. Increasing prevalence of cancer and metabolic disorders are the main factors fuelling the development of the entire market. There have been increased developments in medical science giving rise to different technological advancements in the medical and biopharmaceutical field. The development of peptide drugs at comparatively lower costs of production is spurring the evolution of the global market for peptide therapeutics.

The development of new drugs to treat cancer, owing to rise in the number of patients affected with cancer has a major role in driving the expansion of the peptide therapeutic market on a worldwide basis. However, a main limitation associated with peptide with respect to its complexity can hinder the growth process of the global market for peptide therapeutics.

Global Peptide Therapeutics Market: Competition Scenario     

The research report on global peptide therapeutics market has profiled tier companies involved in the market. Key tier companies such as Amgen Inc., Bachem Holding AG, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Novartis AG, Pfizer Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. are covered in this research report.

Enquire about this Report @ https://www.mrrse.com/enquiry/1023

About MRRSE

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/